|
|
| Buy Digoxin (Lanoxin) online |
How and where to order Digoxin (Lanoxin) 0.25 mg tablets or capsules online:
|
| Shop: | DFH PHARMACY - 10% discount coupon DFH10
|
| Sellers: | DIGOXIN STORES
|
| Prices: | from $0.35 per pill
|
| Forms: | tablets 0.25 mg
|
| Quantity: | 30-360 pills
|
| Type: | Digoxin brand, Lanoxin generic
|
| Payment: | Visa, Mastercard, AmEx, Cryptocurrencies
|
| Delivery: | Regular and express mail service
|
| Shipping: | Worldwide, including USA, UK, Europe, Canada, Australia |
Indications and usage:
Lanoxin (Digoxin) is a cardiac glycoside indicated for:
Treatment of mild to moderate heart failure in adults.
Increasing myocardial contractility in pediatric patients with heart failure.
Control of resting ventricular rate in patients with chronic atrial fibrillation in adults.
Dosage and administration:
Lanoxin tablets dose is based on patient-specific factors (age, lean body weight, renal function, etc.). See full prescribing information. Monitor for toxicity and therapeutic effect.
Dosage forms and strengt:
Lanoxin (Digoxin) unscored tablets: 62.5 mcg, 187.5 mcg.
Lanoxin (Digoxin) scored tablets 125 mcg, 250 mcg.
Contraindications:
Ventricular fibrillation.
Known hypersensitivity to digoxin or other forms of digitalis.
Warnings and precautions:
Risk of rapid ventricular response leading to ventricular fibrillation in patients with AV accessory pathway.
Risk of advanced or complete heart block in patients with sinus node disease and AV block.
Digoxin toxicity: indicated by nausea, vomiting, visual disturbances, and cardiac arrhythmias. Advanced age, low body weight, impaired renal function and electrolyte abnormalities predispose to toxicity.
Risk of ventricular arrhythmias during electrical cardioversion.
Not recommended in patients with acute myocardial infarction.
Avoid Digoxin (Lanoxin) in patients with myocarditis.
Adverse reactions, side effects:
The overall incidence of adverse reactions with digoxin has been reported as 5-20%, with 15-20% of adverse events considered serious. Cardiac toxicity accounts for about one-half, gastrointestinal disturbances for about one-fourth, and CNS and other toxicity for about one-fourth of these adverse events.
To report suspected side effects of Lanoxin (Digoxin) tablets contact GlaxoSmithKline pharmaceutical company, or your local FDA.
Overdosage:
Signs and symptoms in adults and children
The signs and symptoms of toxicity of are generally similar to those described in the adverse reactions but may be more frequent and can be more severe. Signs and symptoms of digoxin toxicity become more frequent with levels above 2 ng/mL. However, in deciding whether a patient's symptoms are due to digoxin, the clinical state together with serum electrolyte levels and thyroid function are important factors.
Treatment
Chronic overdose
If there is suspicion of toxicity, discontinue Lanoxin and place the patient on a cardiac monitor. Correct factors such as electrolyte abnormalities, thyroid dysfunction, and concomitant medications. Correct hypokalemia by administering potassium so that serum potassium is maintained between 4.0 and 5.5 mmol/L. Potassium is usually administered orally, but when correction of the arrhythmia is urgent and serum potassium concentration is low, potassium may be administered by the intravenous route. Monitor electrocardiogram for any evidence of potassium toxicity (e.g., peaking of T waves) and to observe the effect on the arrhythmia. Avoid potassium salts in patients with bradycardia or heart block. Symptomatic arrhythmias may be treated with Digoxin Immune Fab.
Acute overdose
Patients who have intentionally or accidently ingested massive doses of digoxin should receive activated charcoal orally or by nasogastric tube regardless of the time since ingestion since digoxin recirculates to the intestine by enterohepatic circulation. In addition to cardiac monitoring, temporarily discontinue Digoxin (Lanoxin) until the adverse reaction resolves. Correct factors that may be contributing to the adverse reactions. In particular, correct hypokalemia and hypomagnesemia. Digoxin is not effectively removed from the body by dialysis because of its large extravascular volume of distribution. Life threatening arrhythmias (ventricular tachycardia, ventricular fibrillation, high degree A-V block, bradyarrhythma, sinus arrest) or hyperkalemia requires administration of Digoxin Immune Fab. Digoxin Immune Fab has been shown to be 80-90% effective in reversing signs and symptoms of digoxin toxicity. Bradycardia and heart block caused by digoxin are parasympathetically mediated and respond to atropine. A temporary cardiac pacemaker may also be used. Ventricular arrhythmias may respond to lidocaine or phenytoin. When a large amount of digoxin has been ingested, especially in patients with impaired renal function, hyperkalemia may be present due to release of potassium from skeletal muscle. In this case, treatment with Digoxin Immune Fab is indicated; an initial treatment with glucose and insulin may be needed if the hyperkalemia is life-threatening. Once the adverse reaction has resolved, therapy with Lanoxin may be reinstituted following a careful reassessment of dose.
Drug interactions:
Digoxin has a narrow therapeutic index, increased monitoring of serum digoxin concentrations and for potential signs and symptoms of clinical toxicity is necessary when initiating, adjusting, or discontinuing drugs that may interact with digoxin. Prescribers should consult the prescribing information of any drug which is co-prescribed with digoxin for potential drug interaction information.
PGP inducers/inhibitors: drugs that induce or inhibit PGP have the potential to alter digoxin pharmacokinetics.
The potential for drug-drug interactions must be considered prior to and during drug therapy.
Use in specific populations:
Pregnant patients: it is unknown whether use during pregnancy can cause fetal harm.
Pediatric patients: newborn infants display variability in tolerance to digoxin tablets.
Geriatric patients: consider renal function in dosage selection, and carefully monitor for side effects.
Renal impairment: Lanoxin is excreted by the kidneys. Consider renal function during dosage selection.
Patient counseling information:
Advise patients that digoxin is used to treat heart failure and heart arrhythmias.
Instruct patients to take this medication as directed.
Advise patients that many drugs can interact with Lanoxin. Instruct patients to inform their doctor and pharmacist if they are taking any over the counter medications, including herbal medication, or are started on a new prescription.
Advise patient that blood tests will be necessary to ensure that their digoxin dose is appropriate for them.
Advise patients to contact their doctor or a health care professional if they experience nausea, vomiting, persistent diarrhea, confusion, weakness, or visual disturbances (including blurred vision, green-yellow color disturbances, halo effect) as these could be signs that the dose of Lanoxin may be too high.
Advise parents or caregivers that the symptoms of having too high Lanoxin (Digoxin) tablets doses may be difficult to recognize in infants and pediatric patients. Symptoms such as weight loss, failure to thrive in infants, abdominal pain, and behavioral disturbances may be indications of digoxin toxicity.
Instruct the patient to monitor and record their heart rate and blood pressure daily.
Instruct women of childbearing potential who become or are planning to become pregnant to consult a physician prior to initiation or continuing therapy with Lanoxin pills.
Where to buy digoxin online:
To purchase Lanoxin (Digoxin) 0.25 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.
Here is a list of popular medications containing digoxin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
| Trade name of the drug |
Pharmaceutical forms and doses |
Companies |
| Digitek |
Tablets; Oral; 0.125 mg, 0.25 mg |
MylanGlobal Pharmaceuticals |
| Digoxin |
Injectable; Injection; 0.25 mg / mlTablets; Oral; 0.125 mg, 0.25 mg |
Sandoz |
| Lanicor |
Drops; Oral; 0.75 mg / mlInjectable; Injection; 0.25 mg / mlTablets; Oral; 0.25 mg |
RocheHLB PharmaPlivaTeofarmaVargas Laboratorios |
| Lanox |
Injectable; Infusion; 0.25 mg / ml |
Gland PharmaInternational Apex Pharmaceuticals |
| Lanoxin |
Drops; Oral; 0.05 mg / mlElixir; Oral; 0.25 mg / 5 mlInjectable; Injection; 0.25 mg / mlTablets; Oral; 0.0625 mg, 0.125 mg, 0.1875 mg, 0.25 mg, 0.375 mg, 0.5 mg |
GlaxoSmithKlineAspenConcordia PharmaceuticalsCovis PharmaceuticalsDSM PharmaceuticalsEureco-PharmaInvidaMedacMenariniOrion PharmaPharmacarePharmascienceSigma PharmaceuticalsVirco Pharmaceuticals |
| Lanoxin-PG |
Injectable; Injection; 0.05 mg / mlTablets; Oral; 0.0625 mg |
GlaxoSmithKlineAspenInvidaMenariniServipharmStar Pharmaceuticals |
| Sigmaxin |
Tablets; Oral; 0.0625 mg, 0.25 mg |
Sigma PharmaceuticalsAspenFawns & McAllan |
| Toloxin |
Solution; Oral; 0.05 mg / mlTablets; Oral; 0.0625 mg, 0.125 mg, 0.25 mg |
MM TherapeuticsPendopharm |
|
|
|
|
|
|
